ALEMBIC PHARMA Surges by 10%; BSE HEALTHCARE Index Up 5.1%
March 20, 2020 12:26 PM

ALEMBIC PHARMA share price has zoomed 10% and is presently trading at Rs 544.

Meanwhile, the BSE HEALTHCARE Index is at 11,977 (up 5.1%).

Among the top Gainers in the BSE HEALTHCARE Index today are ALEMBIC PHARMA (up 10.2%) and CADILA HEALTHCARE (up 14.9%).

SHILPA MEDICARE (down 2.8%) and SUVEN LIFESCIENCES (down 5.0%) are among the top losers today.

Over the last one year, ALEMBIC PHARMA has moved up from Rs 540 to Rs 544, registering a gain of Rs 4 (up 0.7%).

On the other hand, the BSE HEALTHCARE has moved down from 14,270 to 11,977, loss of 2,293 points (down 16.1%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 88.9%), J.B.CHEMICALS (up 60.7%) and IPCA LABS (up 50.4%).

What About the Benchmark Indices?

The BSE Sensex is at 29,666 (up 4.8%).

The top gainers among the BSE Sensex stocks today are ONGC (up 13.7%), TCS (up 12.3%) and HCL TECHNOLOGIES (up 11.6%). Other gainers include HUL (up 9.8%) and TECH MAHINDRA (up 9.4%). The most traded stocks in the BSE Sensex are ONGC and SBI.

In the meantime, NSE Nifty is at 8,671 (up 4.8%). The top gainers in the NSE Nifty include ONGC (up 14.8%), GAIL (up 12.5%) and TCS (up 12.5%). Other gainers include HCL TECHNOLOGIES (up 11.3%) and WIPRO (up 10.6%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 38,363 to 29,666, registering a loss of 8,697 points (down 22.72%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit stood at Rs 2 billion for the quarter ended December 2019, compared to a profit of Rs 2 billion a year ago. Net Sales rose 18.8% to Rs 12.1 billion during the period as against Rs 10.2 billion in October-December 2018.

For the year ended March 2019, ALEMBIC PHARMA reported 40.8% increase in net profit to Rs 5.9 billion compared to net profit of Rs 4.2 billion during FY18.

Revenue of the company grew 25.7% to Rs 39 billion during FY19.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 14.0x.